Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD).

Cytomegalovirus antivirals database mutation polymorphisms resistance

Journal

Antiviral research
ISSN: 1872-9096
Titre abrégé: Antiviral Res
Pays: Netherlands
ID NLM: 8109699

Informations de publication

Date de publication:
28 Sep 2024
Historique:
received: 27 05 2024
revised: 12 09 2024
accepted: 27 09 2024
medline: 1 10 2024
pubmed: 1 10 2024
entrez: 30 9 2024
Statut: aheadofprint

Résumé

A comprehensive and accessible Herpesvirus drug resistance database was designed to serve as an international reference for diagnosis and clinical studies. This database available at https://www.unilim.fr/cnr-herpesvirus/outils/codexmv/ includes both resistance-related mutations and natural polymorphisms. Initially designed for human cytomegalovirus, it will be expanded to include herpes simplex and varicella-zoster viruses. Newly published mutations and new mutations reported by users or collaborating expert laboratories will be reviewed by an international committee of reference laboratories before inclusion in the database. Coupled with the Herpesvirus Sequence Analysis tool (HSA) mutation reports from NGS or Sanger sequences, it will be an open source for researchers in the field of Herpesviruses. We hope to fill this unmet need for the development and standardization of resistance genotyping.

Identifiants

pubmed: 39349222
pii: S0166-3542(24)00225-0
doi: 10.1016/j.antiviral.2024.106016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106016

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest This comprehensive Antiviral Resistance database was developed by S. Alain, V. Tilloy, D. Díaz-González and S. Hantz at Limoges hospital as part of the ‘Centre National de Référence des Herpèsvirus’ tasks. The CHARMD database and the HSA tool, whose creators are among the authors of the article, are currently being registered with the French Agency for the Protection of Programs.

Auteurs

Valentin Tilloy (V)

Centre National de Référence des Herpèsvirus, CHU Limoges, Limoges, France; UF9481 Bioinformatique, CHU Limoges, Limoges, France; UF8843 Génomique médicale, CHU Limoges, Limoges, France; Inserm, U1092, RESINFIT, Université de Limoges, Limoges, France. Electronic address: valentin.tilloy@unilim.fr.

Daniel Díaz-González (D)

Centre National de Référence des Herpèsvirus, CHU Limoges, Limoges, France; UF9481 Bioinformatique, CHU Limoges, Limoges, France; UF8843 Génomique médicale, CHU Limoges, Limoges, France.

Lisa Laplace (L)

Centre National de Référence des Herpèsvirus, CHU Limoges, Limoges, France.

Emilien Bisserier (E)

Centre National de Référence des Herpèsvirus, CHU Limoges, Limoges, France.

Sunwen Chou (S)

Department of Veterans Affairs Medical Center, Portland. Oregon, USA.

William D Rawlinson (WD)

Virology and OTDS Laboratories (SAViD), Prince of Wales Hospital, Barker Street, Randwick NSW 2031, NSW Health Pathology Randwick, Australia.

Guy Boivin (G)

Centre de recherche en infectiologie, CHU de Québec-Université Laval, Canada.

Fausto Baldanti (F)

Fondazione IRCCS Policlinico San Matteo di Pavia, Italy.

Tiziana Lazzarotto (T)

Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna, Italy.

Graciela Andrei (G)

Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.

Hans H Hirsch (HH)

Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.

María Ángeles Marcos (MÁ)

Servicio de Microbiología, Hospital clinic, ISGlobal (Instituto de Salud Global de Barcelona), Barcelona, Spain.

Detlef Michel (D)

Institute of Virology, ULM University, Germany.

Sébastien Hantz (S)

Centre National de Référence des Herpèsvirus, CHU Limoges, Limoges, France; Inserm, U1092, RESINFIT, Université de Limoges, Limoges, France.

Sophie Alain (S)

Centre National de Référence des Herpèsvirus, CHU Limoges, Limoges, France; UF8843 Génomique médicale, CHU Limoges, Limoges, France; Inserm, U1092, RESINFIT, Université de Limoges, Limoges, France. Electronic address: sophie.alain@unilim.fr.

Classifications MeSH